Point of Care Testing Market Share Forecasts 2025-2034

Point of Care Testing Market - By Product, By Technology, By Application, By Prescription, By End Use - Global Forecast, 2025 - 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Global

1.3.2&nbsp;&nbsp;&nbsp; Regional/Country

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Regional trends

2.2.2&nbsp;&nbsp;&nbsp; Products trends

2.2.3&nbsp;&nbsp;&nbsp; Technology trends

2.2.4&nbsp;&nbsp;&nbsp; Prescription trends

2.2.5&nbsp;&nbsp;&nbsp; Application trends

2.2.6&nbsp;&nbsp;&nbsp; End use trends

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Upward trend in disease prevalence among developing countries

3.2.1.2&nbsp;&nbsp;&nbsp; Surging number of pathology labs and services equipped with advanced diagnostic equipment

3.2.1.3&nbsp;&nbsp;&nbsp; Technological advancements in point of care tests

3.2.1.4&nbsp;&nbsp;&nbsp; Increasing research and development investment

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Stringent regulatory framework

3.2.2.2&nbsp;&nbsp;&nbsp; High cost of product development

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Growing demand in remote and rural areas

3.2.3.2&nbsp;&nbsp;&nbsp; Integration with digital health platforms

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.4.1&nbsp;&nbsp;&nbsp; North America

3.4.2&nbsp;&nbsp;&nbsp; Asia Pacific

3.4.3&nbsp;&nbsp;&nbsp; Europe

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.6&nbsp;&nbsp;&nbsp; Future market trends

3.7&nbsp;&nbsp;&nbsp; Gap analysis

3.8&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

4.7&nbsp;&nbsp;&nbsp; Key developments

4.7.1&nbsp;&nbsp;&nbsp; Mergers and acquisitions

4.7.2&nbsp;&nbsp;&nbsp; Partnerships and collaborations

4.7.3&nbsp;&nbsp;&nbsp; New product launches

4.7.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 - 2034 ($ Bn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Endocrinology testing products

5.2.1&nbsp;&nbsp;&nbsp; Glucose monitoring

5.2.1.1&nbsp;&nbsp;&nbsp; Strips

5.2.1.2&nbsp;&nbsp;&nbsp; Meters

5.2.1.3&nbsp;&nbsp;&nbsp; Lancets

5.2.2&nbsp;&nbsp;&nbsp; Cholesterol testing products

5.2.3&nbsp;&nbsp;&nbsp; Pregnancy testing products

5.2.4&nbsp;&nbsp;&nbsp; Fertility testing products

5.2.5&nbsp;&nbsp;&nbsp; Thyroid function tests

5.3&nbsp;&nbsp;&nbsp; Cardiometabolic testing products

5.3.1&nbsp;&nbsp;&nbsp; Cardiac marker testing products

5.3.1.1&nbsp;&nbsp;&nbsp; hsTnI (High-Sensitivity Troponin I)

5.3.1.2&nbsp;&nbsp;&nbsp; BNP (B-Type Natriuretic Peptide)

5.3.1.3&nbsp;&nbsp;&nbsp; D-dimer

5.3.1.4&nbsp;&nbsp;&nbsp; CK-MB (Creatine Kinase-MB)

5.3.1.5&nbsp;&nbsp;&nbsp; Myoglobin

5.3.1.6&nbsp;&nbsp;&nbsp; Other Cardiac Marker Testing

5.3.2&nbsp;&nbsp;&nbsp; Blood gas (Lung function)

5.3.3&nbsp;&nbsp;&nbsp; Metabolite testing products

5.3.3.1&nbsp;&nbsp;&nbsp; Electrolytes testing

5.3.3.2&nbsp;&nbsp;&nbsp; Liver function

5.3.3.2.1&nbsp;&nbsp;&nbsp; Bilirubin

5.3.3.2.2&nbsp;&nbsp;&nbsp; Alanine transaminase (ALT)

5.3.3.3&nbsp;&nbsp;&nbsp; Kidney function

5.3.3.3.1&nbsp;&nbsp;&nbsp; Creatinine

5.3.3.3.2&nbsp;&nbsp;&nbsp; Urea

5.3.3.3.3&nbsp;&nbsp;&nbsp; Uric Acid

5.3.4&nbsp;&nbsp;&nbsp; HBA1C testing products

5.4&nbsp;&nbsp;&nbsp; Infectious disease testing products

5.4.1&nbsp;&nbsp;&nbsp; Influenza testing products

5.4.2&nbsp;&nbsp;&nbsp; HIV testing products

5.4.3&nbsp;&nbsp;&nbsp; Hepatitis C testing products

5.4.4&nbsp;&nbsp;&nbsp; Sexually transmitted disease (STD) testing products

5.4.5&nbsp;&nbsp;&nbsp; Healthcare-associated infection (HAI) testing products

5.4.6&nbsp;&nbsp;&nbsp; Respiratory infection testing products

5.4.7&nbsp;&nbsp;&nbsp; Tropical disease testing products

5.4.8&nbsp;&nbsp;&nbsp; Other infectious disease testing products

5.5&nbsp;&nbsp;&nbsp; Coagulation testing products

5.5.1&nbsp;&nbsp;&nbsp; PT/INR testing products

5.5.2&nbsp;&nbsp;&nbsp; Activated clotting time (ACT/APTT) testing products

5.6&nbsp;&nbsp;&nbsp; Tumor/cancer marker testing products

5.7&nbsp;&nbsp;&nbsp; Urinalysis testing products

5.8&nbsp;&nbsp;&nbsp; Hematology testing products

5.9&nbsp;&nbsp;&nbsp; Drug-of-abuse (DoA) testing products

5.10&nbsp;&nbsp;&nbsp; Fecal occult testing products

5.11&nbsp;&nbsp;&nbsp; Other products

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Technology, 2021 - 2034 ($ Bn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Lateral flow assays

6.3&nbsp;&nbsp;&nbsp; Dipsticks

6.4&nbsp;&nbsp;&nbsp; Microfluidics

6.5&nbsp;&nbsp;&nbsp; Molecular diagnostics

6.6&nbsp;&nbsp;&nbsp; Immunoassays

6.7&nbsp;&nbsp;&nbsp; Agglutination assays

6.8&nbsp;&nbsp;&nbsp; Flow-through

6.9&nbsp;&nbsp;&nbsp; Solid phase

6.10&nbsp;&nbsp;&nbsp; Biosensors

6.10.1&nbsp;&nbsp;&nbsp;Electrochemical

6.10.2&nbsp;&nbsp;&nbsp;Optical

6.10.3&nbsp;&nbsp;&nbsp;Thermal

6.10.4&nbsp;&nbsp;&nbsp;Mass-sensitive

6.10.5&nbsp;&nbsp;&nbsp;Other biosensors

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 - 2034 ($ Bn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Cardio metabolic testing

7.3&nbsp;&nbsp;&nbsp; Infectious disease testing

7.4&nbsp;&nbsp;&nbsp; Nephrology testing

7.5&nbsp;&nbsp;&nbsp; Drug-of-abuse (DoA) testing

7.6&nbsp;&nbsp;&nbsp; Blood glucose testing

7.7&nbsp;&nbsp;&nbsp; Pregnancy testing

7.8&nbsp;&nbsp;&nbsp; Cancer biomarker testing

7.9&nbsp;&nbsp;&nbsp; Other applications

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Prescription, 2021 - 2034 ($ Bn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; OTC testing

8.3&nbsp;&nbsp;&nbsp; Prescription-based testing

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Bn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; Hospitals

9.3&nbsp;&nbsp;&nbsp; Diagnostic centers

9.4&nbsp;&nbsp;&nbsp; Research laboratories

9.5&nbsp;&nbsp;&nbsp; Home-care settings

9.6&nbsp;&nbsp;&nbsp; Other end use

Chapter 10&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 - 2034 ($ Bn)

10.1&nbsp;&nbsp;&nbsp; Key trends

10.2&nbsp;&nbsp;&nbsp; North America

1.1.1&nbsp;&nbsp;&nbsp; U.S.

1.1.2&nbsp;&nbsp;&nbsp; Canada

10.3&nbsp;&nbsp;&nbsp; Europe

1.1.3&nbsp;&nbsp;&nbsp; Germany

1.1.4&nbsp;&nbsp;&nbsp; UK

1.1.5&nbsp;&nbsp;&nbsp; France

1.1.6&nbsp;&nbsp;&nbsp; Spain

1.1.7&nbsp;&nbsp;&nbsp; Italy

1.1.8&nbsp;&nbsp;&nbsp; Netherlands

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

1.1.9&nbsp;&nbsp;&nbsp; China

1.1.10&nbsp;&nbsp;&nbsp;Japan

1.1.11&nbsp;&nbsp;&nbsp;India

1.1.12&nbsp;&nbsp;&nbsp;Australia

1.1.13&nbsp;&nbsp;&nbsp;South Korea

10.5&nbsp;&nbsp;&nbsp; Latin America

1.1.14&nbsp;&nbsp;&nbsp;Brazil

1.1.15&nbsp;&nbsp;&nbsp;Mexico

1.1.16&nbsp;&nbsp;&nbsp;Argentina

10.6&nbsp;&nbsp;&nbsp; Middle East and Africa

1.1.17&nbsp;&nbsp;&nbsp;South Africa

1.1.18&nbsp;&nbsp;&nbsp;Saudi Arabia

1.1.19&nbsp;&nbsp;&nbsp;UAE

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

11.2&nbsp;&nbsp;&nbsp; Acon Laboratories

11.3&nbsp;&nbsp;&nbsp; Becton, Dickinson, and Company

11.4&nbsp;&nbsp;&nbsp; BioMerieux SA

11.5&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories, Inc.

11.6&nbsp;&nbsp;&nbsp; Danaher Corporation

11.7&nbsp;&nbsp;&nbsp; Dexcom, Inc

11.8&nbsp;&nbsp;&nbsp; Dr&auml;gerwerk AG &amp; Co. KGaA

11.9&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche Ltd.

11.10&nbsp;&nbsp;&nbsp; LifeScan IP Holdings, LLC

11.11&nbsp;&nbsp;&nbsp; Medtronic Plc

11.12&nbsp;&nbsp;&nbsp; Meridian Bioscience, Inc.

11.13&nbsp;&nbsp;&nbsp; Nova Biomedical

11.14&nbsp;&nbsp;&nbsp; QuidelOrtho Corporation

11.15&nbsp;&nbsp;&nbsp; Siemens Healthineers AG

11.16&nbsp;&nbsp;&nbsp; Sysmex Corporation 
&nbsp;

Point of Care Testing Market

Inquiry Before Buying